Skip to content

SEC FORM 4

Aurinia Pharmaceuticals Inc. (AUPH) insider transactions

Recent insider purchases and sales reported on SEC Form 4, with transaction date, insider, role, shares, price and a direct SEC source for every row.

Last updated: 09/12/2026, 06:35 AM UTCAll AUPH stock data
Recent transactions
12
Insiders
2
Purchases / sales
10 / 2
Reported transaction value
$25.67M

SEC Form 4 transactions

Newest filings first
TANG KEVIN

이사 · Chief Executive Officer · 10% 이상 보유자

Purchase
Shares
206,005
Price
$15.28
Value
$3.15M
Date
Jun 02, 2026
TANG KEVIN

이사 · Chief Executive Officer · 10% 이상 보유자

Purchase
Shares
343,521
Price
$15.28
Value
$5.25M
Date
Jun 01, 2026
TANG KEVIN

이사 · Chief Executive Officer · 10% 이상 보유자

Purchase
Shares
99
Price
$15.34
Value
$1.52K
Date
Jun 01, 2026
TANG KEVIN

이사 · Chief Executive Officer · 10% 이상 보유자

Purchase
Shares
262,682
Price
$15.31
Value
$4.02M
Date
May 29, 2026
TANG KEVIN

이사 · Chief Executive Officer · 10% 이상 보유자

Purchase
Shares
2,299
Price
$15.35
Value
$35.29K
Date
May 29, 2026

How to read this dataset

Only transactions explicitly classified as purchase (P) or sale (S) are shown. A filing does not guarantee the insider's outlook or future investment performance.